Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Danielle Kim Turgeon
With
Olympus Corporation
Age
18–100
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects felt to be at increased risk for CRC and colonic polyps
OR
Subjects with known colonic adenomas scheduled for colonic resection
OR
Subjects who are scheduled for outpatient colonoscopy for follow up surveillance of IBD with known dysplasia or who are at high risk for high grade dysplasia.
Subjects who are scheduled for outpatient colonoscopy in the medical procedures unit at the University of Michigan Health Center
You may not be if
Adults aged 18 to 100 years
Willing and able to sign informed consent
The effects of Colon KCC Heptapeptide (5-FITC-labeled peptide) on the developing human fetus are unknown. For this reason, women of childbearing potential must have a negative pregnancy test on the day of the procedure prior to receiving the Colon KCC Heptapeptide (5-FITC-labeled peptide agent) or be post-menopausal. Post-menopausal women are defined as post-hysterectomy, or over 40 and at least 18 months without menses and not on birth-control.
Subjects with known allergy or negative reaction to fluorescein or derivatives.
Subjects on active chemotherapy or radiation treatment
Pregnant or trying to conceive
Clareo Health | Study of KCC Peptide Application in the Colon
